P1063 Long-term safety and tolerability of repeated treatments with onabotulinumtoxinA in children with neurogenic detrusor overactivity
Franco I, Dobremez E, Hoebeke P, Titanji W, Yushmanova I, Jenkins B, Austin P. P1063 Long-term safety and tolerability of repeated treatments with onabotulinumtoxinA in children with neurogenic detrusor overactivity. European Urology 2021, 79: s1506-s1507. DOI: 10.1016/s0302-2838(21)01435-4.Peer-Reviewed Original ResearchEfficacy and safety of three active doses of onabotulinumtoxinA for the treatment of neurogenic detrusor overactivity in children: Results of a randomized controlled clinical trial
Austin P, Franco I, Dobremez E, Kroll P, Titanji W, Geib T, Jenkins B, Hoebeke P. Efficacy and safety of three active doses of onabotulinumtoxinA for the treatment of neurogenic detrusor overactivity in children: Results of a randomized controlled clinical trial. Toxicon 2021, 190: s6. DOI: 10.1016/j.toxicon.2020.11.352.Peer-Reviewed Original Research